David J. Kupfer, M.D.

Name, Degree:  David J. Kupfer, M.D.
Role(s) in Task Force and Work Group:  Chair, DSM-V Task Force
Institutional Affiliation(s): University of Pittsburgh School of Medicine / Western Psychiatric Inst. & Clinic
City, State:  Pittsburgh, PA

Biographical Sketch:

David J. Kupfer, M.D. - Chair, DSM-V Task ForceProfessor and Chair, Department of Psychiatry, University of Pittsburgh School of MedicineMedical Director and Director of Research, Western Psychiatric Institute and Clinic
Pittsburgh, PA

In 1970, Dr. Kupfer was appointed assistant professor of psychiatry at Yale University School of Medicine.  He then joined the faculty at the University of Pittsburgh in 1973 as an associate professor of psychiatry and director of research and research training at Western Psychiatric Institute and Clinic (WPIC).  He was promoted to professor in 1975 and named Department Chair in 1983.  As Thomas Detre Professor and chair of the department of psychiatry and director of research at WPIC, he has promoted widespread collaborations between clinical investigators in psychiatry and those in more basic neurosciences.

Dr. Kupfer earned his B.A. from Yale University magna cum laude and his medical degree from Yale University.  After completing a medical internship at Montefiore Hospital Center in New York, he continued his postgraduate clinical and research training in psychiatry at the Yale–New Haven Hospital and at the National Institute of Mental Health, Intramural Research Program.

An internationally recognized expert on both mood and sleep disorders, he holds membership in many professional societies, including the Society of Biological Psychiatry, the American College of Neuropsychopharmacology, the American Psychosomatic Society, the Society for Psychotherapy Research, the Collegium Internationale Neuro-Psychopharmacologicum, the Association of American Physicians, the American College of Psychiatrists, and the American Psychiatric Association, where he has served as a member of the DSM-IV Task Force, Chair of the Council on Research, and Chair of the Committee on Psychiatric Diagnosis and Assessment.  In 1990, he was elected to membership in the Institute of Medicine of the National Academy of Sciences. Dr. Kupfer also served as the senior editor of the book entitled A Research Agenda for DSM-V, which was published in 2002.

Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V :   Three calendar years before  nomination and Each year thereafter through the present calendar year.  (For 2008, activities to date and commitments for remainder of year.)

Non-Profit and Advocacy Organizations

Year(s)

Role

Fondazione IDEA, Italy

2005-2008

Scientific Committee

National Foundation for Mental Health

 

2005-2008

Board of Directors

Community Care Behavioral Health Organization

 

2005-2008

Board of Directors

American Psychiatric Association

2005

Chair, Council of Research

Depression and Bipolar Support Alliance

2003-2004

Vice Chair, Scientific Advisory Council

The two tables below represent Dr. David J. Kupfer’s disclosure of significant interests and affiliations for:  (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present. 

Dr. David J. Kupfer  has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, his aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.

KEY NUMBER:
1. Consultation Fees  (include scientific advisory boards)
2. Full- or Part-time Employee
3. Industry-related Grant-Research Support received or pending
4. Honoraria (includes Speakers’ Bureau)
5. Stock or other financial options 

6. Expert testimony
7.  Royalties (including right to share of revenue or profit from pharmaceutical, device or other development or product)
8. Patents received or pending
9. Officer, director/trustee, executive (specify)
10.  Other  (specify)

Disclosure of significant interests including:  Three (3) calendar years before nomination, the calendar year of nomination through the calendar year of approval to serve on the DSM-V Task Force

Commercial or Other Organization

Year(s)

Key #(s)

Innovative Medical Education 

2003-2006

1

Deborah Wood and Associates 

2003-2006

1

TG Worldwide 

2003

1

JK Associates 

2003

1

Physicians Post-Graduate Press 

2003-2004

1

SCS Health Care 

2005-2006

1

Prescott Communications 

2003-2004

1

Cardinal Associates 

2004

1

Pharmedica Communications 

2004

1

Current Psychiatry 

2004

1

Eli Lilly and Co. 

2003 – 2006

1

Corcept, Inc 

2003

1

Forest Pharmaceuticals 

2003 – 2004

1

Pfizer, Inc. 

2003 – 2006

1

Johnson & Johnson 

2005-2006

1

Servier Amerique 

2005

1

Solvay Wyeth 

2005-2006

1

BodyMedia, Inc.

2003-2007

10 (Board member, Uncompensated)

Hoffman LaRoche 

2003

1

Lundbeck 

2006

1

Novartis

2004

1

Heinz C. Prechter Fund for Manic Depression

2004-2007

10 (Foundation Support)

Disclosure of significant interests beginning with the calendar year after APA Board of Trustees approval to serve on the DSM-V Task Force, to the present. (For 2008, activities to date and commitments for remainder of year.)

Commercial or Other Organization

Year(s)

Key #(s)

BodyMedia Inc.

2008

10 (Board member, Uncompensated)

Heinz C. Prechter Fund for Manic Depression

2008

10 (Foundation Support)

From: 
Email:  
To: 
Email:  
Subject: 
Message: